Allurion, a Boston-based startup offering a non-invasive gastric balloon by swallowing a pill, has gained $27 million in Series C funding from previous investor Romulus Capital, with new participation from Cogepa Investments and IDO Investments, an innovation firm based in Oman. Read More

from iFeeltech IT News Mix4 https://techcrunch.com/2017/07/11/gastric-bypass-surgery-in-a-pill-startup-allurion-gets-27-million-as-it-pursues-fda-approval/?ncid=rss

Advertisements